Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INPP4B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | SH3PXD2A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CEBPZOS | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | NBPF10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | SHC4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CD70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | ZNF121 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GDE1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | COPZ2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |